1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 2017, 195:557-582.
2. Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22:672-688.
3. Vlahos R, Bozinovski S: Recent advances in pre-clinical mouse models of COPD. Clin Sci 2014, 126:253-265.
4. Bozinovski S, Seow HJ, Chan SP, Anthony D, McQualter J, Hansen M, Jenkins BJ, Anderson GP, Vlahos R: Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette- smoke-induced lung inflammation in mice. Clin Sci 2015, 129:785-796.
5. Rahman I, Morrison D, Donaldson K, MacNee W: Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996, 154:1055-1060.
6. Bernardo I, Bozinovski S, Vlahos R: Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities. Pharmacol Ther 2015, 155:60-79.
7. Brassington K, Chan SMH, Seow HJ, Dobric A, Bozinovski S, Selemidis S, Vlahos R: Ebselen reduces cigarette smoke-induced vascular endothelial dysfunction in mice. Br J Pharmacol 2021, 178:1805-1818.
8. Chan SMH, Bernardo I, Mastronado C, Mou K, De Luca SN, Seow HJ, Dobric A, Brassington K, Selemidis S, Bozinovski S, Vlahos R: Apocynin prevents cigarette smoking-induced loss of skeletal muscle mass and function by preserving proteostatic signalling. Br J Pharmacol 2021, 178:3049-3066.
9. Duong C, Seow HJ, Bozinovski S, Crack PJ, Anderson GP, Vlahos R: Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2010, 299:L425-433.
10. Oostwoud LC, Gunasinghe P, Seow HJ, Ye JM, Selemidis S, Bozinovski S, Vlahos R: Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice. Sci Rep 2016, 6:20983.
11. Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185.
12. Dodd JW: Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res The 2015, 7:32-32.
13. Yazar EE, Aydin S, Gunluoglu G, Kamat S, Gungen AC, Yildiz P: Clinical effects of cognitive impairment in patients with chronic obstructive pulmonary disease. Chronic Respir Dis 2018, 15:306-314.
14. Shehata MEDA, Samaha HMS, Elsaid AR, Helmy EM, Mustafa W: Magnetic resonance apparent diffusion coefficient values of the brain in COPD. Egypt J Chest Dis Tuberc 2017, 66:237-242.
15. Yohannes AM, N Eakin M, Holbrook JT, Sugar EA, Henderson R, Baker AM, Casper AS, Kaminsky DA, Rea AL, Mathews AM, et al: Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. Expert Rev Respir Med 2021, 15:153-159.
16. France G, Orme MW, Greening NJ, Steiner MC, Chaplin EJ, Clinch L, Singh SJ: Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD. Respir Med 2021, 176:106249.
17. Antonelli-Incalzi R, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, Izzo O, Rengo F: Drawing impairment predicts mortality in severe COPD. Chest 2006, 130:1687-1694.
18. Tashkin DP: Smoking Cessation in Chronic Obstructive Pulmonary Disease. Semin Respir Crit Care Med 2015, 36:491-507.
19. Warnier MJ, van Riet EE, Rutten FH, De Bruin ML, Sachs AP: Smoking cessation strategies in patients with COPD. Eur Respir J 2013, 41:727-734.
20. Godtfredsen NS, Lam TH, Hansel TT, Leon ME, Gray N, Dresler C, Burns DM, Prescott E, Vestbo J: COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J 2008, 32:844-853.
21. Liang J, Abramson MJ, Zwar NA, Russell GM, Holland AE, Bonevski B, Mahal A, Phillips K, Eustace P, Paul E, et al: Diagnosing COPD and supporting smoking cessation in general practice: evidence-practice gaps. Med J Aust 2018, 208:29-34.
22. Sabia S, Elbaz A, Dugravot A, Head J, Shipley M, Hagger-Johnson G, Kivimaki M, Singh-Manoux A: Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study. Arch Gen Psychiatry 2012, 69:627-635.
23. Hu M, Yin H, Shu X, Jia Y, Leng M, Chen L: Multi-angles of smoking and mild cognitive impairment: is the association mediated by sleep duration? Neurol Sci 2019, 40:1019-1027.
24. Almeida OP, Garrido GJ, Alfonso H, Hulse G, Lautenschlager NT, Hankey GJ, Flicker L: 24-month effect of smoking cessation on cognitive function and brain structure in later life. Neuroimage 2011, 55:1480-1489.
25. De Luca SN, Soch A, Sominsky L, Nguyen T-X, Bosakhar A, Spencer SJ: Glial remodeling enhances short-term memory performance in Wistar rats. J Neuroinflam 2020, 17:52-52.
26. Nimmerjahn A, Kirchhoff F, Helmchen F: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
27. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB: ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience 2005, 8:752-758.
28. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T: Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. PNAS 2003, 100:8514-8519.
29. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW: Cytotoxicity of microglia. Glia 1993, 7:111-118.
30. Lull ME, Block ML: Microglial activation and chronic neurodegeneration. Neurotherapeutics 2010, 7:354-365.
31. Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al: The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Experiment Physiol 2020, 105:1459-1466.
32. Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, Lilja A, Hansen MJ, Gualano RC, Irving L, Anderson GP: Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 2006, 290:L931-945.
33. Chan SMH, Cerni C, Passey S, Seow HJ, Bernardo I, Poel Cvd, Dobric A, Brassington K, Selemidis S, Bozinovski S, Vlahos R: Cigarette Smoking Exacerbates Skeletal Muscle Injury Without Compromising its Regenerative Capacity. Am J Respir Cell Mol 2020, 62:217-230.
34. Hepworth ML, Passey SL, Seow HJ, Vlahos R: Losartan does not inhibit cigarette smoke-induced lung inflammation in mice. Sci Rep 2019, 9:15053.
35. Franklin KBJ, Paxinos G: The Mouse Brain in Stereotaxic Coordinates. Elsevier 2005, Compact second edition.
36. Hammond RS, Tull LE, Stackman RW: On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 2004, 82:26-34.
37. Antunes M, Biala G: The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 2012, 13.
38. De Cunto G, Bartalesi B, Cavarra E, Balzano E, Lungarella G, Lucattelli M: Ongoing Lung Inflammation and Disease Progression in Mice after Smoking Cessation: Beneficial Effects of Formyl-Peptide Receptor Blockade. Am J Pathol 2018, 188:2195-2206.
39. Deal JA, Power MC, Palta P, Alonso A, Schneider ALC, Perryman K, Bandeen-Roche K, Sharrett AR: Relationship of Cigarette Smoking and Time of Quitting with Incident Dementia and Cognitive Decline. J Am Geriatr Soc 2020, 68:337-345.
40. Noé-Díaz V, Salinas-Rivera E, Cruz-Pérez F, García-Gómez LA, Mandujano-Baeza E, Ortiz-Moncada G, Ramírez-Venegas A, Sansores RH: Changes on executive functions before and after quitting smoking: Pilot study. JSubst Use 2018, 23:452-456.
41. Lu Y, Sugawara Y, Zhang S, Tomata Y, Tsuji I: Smoking cessation and incident dementia in elderly Japanese: the Ohsaki Cohort 2006 Study. Eur J Epidemiol 2020, 35:851-860.
42. Choi D, Choi S, Park SM: Effect of smoking cessation on the risk of dementia: a longitudinal study. Ann Clin Transl Neurol 2018, 5:1192-1199.
43. Mons U, Schöttker B, Müller H, Kliegel M, Brenner H: History of lifetime smoking, smoking cessation and cognitive function in the elderly population. Eur J Epidemiol 2013, 28:823-831.
44. Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C: Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend 2010, 106:61-64.
45. Saravia R, Flores A, Plaza-Zabala A, Busquets-Garcia A, Pastor A, de la Torre R, Di Marzo V, Marsicano G, Ozaita A, Maldonado R, Berrendero F: CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal. Biol Psychiatry 2017, 81:625-634.
46. Saravia R, Ten-Blanco M, Grande MT, Maldonado R, Berrendero F: Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice. Brain Behav Immun 2019, 75:228-239.
47. Cole RD, Zimmerman M, Matchanova A, Kutlu MG, Gould TJ, Parikh V: Cognitive rigidity and BDNF-mediated frontostriatal glutamate neuroadaptations during spontaneous nicotine withdrawal. Neuropsychopharmacology 2020, 45:866-876.
48. Gould TJ, Wilkinson DS, Yildirim E, Blendy JA, Adoff MD: Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear. Brain Res 2014, 1559:1-10.
49. Semenova S, Stolerman IP, Markou A: Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacol Biochem Behav 2007, 87:360-368.
50. Shao XM, Xu B, Liang J, Xie XS, Zhu Y, Feldman JL: Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smoking. Nicotine Tob Res 2013, 15:1248-1258.
51. Ponzoni L, Braida D, Carboni L, Moretti M, Viani P, Clementi F, Zoli M, Gotti C, Sala M: Persistent cognitive and affective alterations at late withdrawal stages after long-term intermittent exposure to tobacco smoke or electronic cigarette vapour: Behavioural changes and their neurochemical correlates. Pharmacol Res 2020, 158:104941.
52. Ponzoni L, Moretti M, Sala M, Fasoli F, Mucchietto V, Lucini V, Cannazza G, Gallesi G, Castellana CN, Clementi F, et al: Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice. Eur Neuropsychopharmacol 2015, 25:1775-1786.
53. Heldt NA, Seliga A, Winfield M, Gajghate S, Reichenbach N, Yu X, Rom S, Tenneti A, May D, Gregory BD, Persidsky Y: Electronic cigarette exposure disrupts blood-brain barrier integrity and promotes neuroinflammation. Brain Behav Immun 2020, 88:363-380.
54. Ghosh D, Mishra MK, Das S, Kaushik DK, Basu A: Tobacco carcinogen induces microglial activation and subsequent neuronal damage. J Neurochem 2009, 110:1070-1081.
55. Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL, et al: Effect of overnight smoking abstinence on a marker for microglial activation: a [(11)C]DAA1106 positron emission tomography study. Psychopharmacology 2018, 235:3525-3534.
56. Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA: Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [(11)C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology 2017, 42:1630-1639.
57. Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M: Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 2010, 9:971-988.
58. Venneti S, Lopresti BJ, Wang G, Slagel SL, Mason NS, Mathis CA, Fischer ML, Larsen NJ, Mortimer AD, Hastings TG, et al: A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. J Neurochem 2007, 102:2118-2131.
59. Yao R, Pan R, Shang C, Li X, Cheng J, Xu J, Li Y: Translocator Protein 18 kDa (TSPO) Deficiency Inhibits Microglial Activation and Impairs Mitochondrial Function. Front Pharmacol 2020, 11.
60. Ballweg K, Mutze K, Königshoff M, Eickelberg O, Meiners S: Cigarette smoke extract affects mitochondrial function in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2014, 307:L895-L907.
61. Dikalov S, Itani H, Richmond B, Arslanbaeva L, Vergeade A, Rahman SMJ, Boutaud O, Blackwell T, Massion PP, Harrison DG, Dikalova A: Tobacco smoking induces cardiovascular mitochondrial oxidative stress, promotes endothelial dysfunction, and enhances hypertension. Am J Physiol Heart Circ Physiol 2019, 316:H639-H646.
62. Cope EC, LaMarca EA, Monari PK, Olson LB, Martinez S, Zych AD, Katchur NJ, Gould E: Microglia play an active role in obesity-associated cognitive decline. J Neurosci 2018:0789-0718.
63. Jiang Y, Liu Y, Zhu C, ma X, Ma L, Zhou L, Huang Q, Cen L, Pi R: Minocycline enhances hippocampal memory, neuroplasticity and synapse-associated proteins in aged C57 BL/6 mice. Neurobiol Learn Mem 2015, 121.
64. Dalvi PS, Singh A, Trivedi HR, Ghanchi FD, Parmar DM, Mistry SD: Effect of doxycycline in patients of moderate to severe chronic obstructive pulmonary disease with stable symptoms. Ann Thorac Med 2011, 6:221-226.
65. Kandlur A, Satyamoorthy K, Gangadharan G: Oxidative Stress in Cognitive and Epigenetic Aging: A Retrospective Glance. Front Mol Neurosci 2020, 13.
66. Khanna A, Guo M, Mehra M, Royal W, 3rd: Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains. J Neuroimmunol 2013, 254:69-75.
67. Sivandzade F, Alqahtani F, Sifat A, Cucullo L: The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo study. J Neuroinflam 2020, 17:133.
68. Ding X, Zhang M, Gu R, Xu G, Wu H: Activated microglia induce the production of reactive oxygen species and promote apoptosis of co-cultured retinal microvascular pericytes. Graefes Arch Clin Exp Ophthalmol 2017, 255:777-788.
69. Brown GC, Neher JJ: Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010, 41:242-247.
70. Sierra A, Navascués J, Cuadros MA, Calvente R, Martín-Oliva D, Ferrer-Martín RM, Martín-Estebané M, Carrasco MC, Marín-Teva JL: Expression of inducible nitric oxide synthase (iNOS) in microglia of the developing quail retina. PLoS One 2014, 9:e106048.
71. Ozkan A, Fiskin K, Ayhan AG: Effect of vitamin E and selenium on antioxidant enzymes in brain, kidney and liver of cigarette smoke-exposed mice. Biologia 2007, 62:360-364.
72. Salim S: Oxidative Stress and the Central Nervous System. J Pharmacol Exp Ther 2017, 360:201-205.
73. Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW, Jr., Morris JC: Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 2001, 56:127-129.
74. Coley AA, Gao WJ: PSD-95 deficiency disrupts PFC-associated function and behavior during neurodevelopment. Sci Rep 2019, 9.
75. Deng XH, Ai WM, Lei DL, Luo XG, Yan XX, Li Z: Lipopolysaccharide induces paired immunoglobulin-like receptor B (PirB) expression, synaptic alteration, and learning-memory deficit in rats. Neuroscience 2012, 209:161-170.
76. Schmitt U, Tanimoto N, Seeliger M, Schaeffel F, Leube RE: Detection of behavioral alterations and learning deficits in mice lacking synaptophysin. Neuroscience 2009, 162:234-243.
77. Xie Y, Tan Y, Zheng Y, Du X, Liu Q: Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice. J Biol Inorg Chem 2017, 22:851-865.
78. Zhang X, Shen X, Dong J, Liu W-C, Song M, Sun Y, Shu H, Towse C-L, Liu W, Liu C-F, Jin X: Inhibition of Reactive Astrocytes with Fluorocitrate Ameliorates Learning and Memory Impairment Through Upregulating CRTC1 and Synaptophysin in Ischemic Stroke Rats. Cell Mol Neurobiol 2019, 39:1151-1163.
79. Chen YY, Zhang L, Shi DL, Song XH, Shen YL, Zheng MZ, Wang LL: Resveratrol Attenuates Subacute Systemic Inflammation-Induced Spatial Memory Impairment via Inhibition of Astrocyte Activation and Enhancement of Synaptophysin Expression in the Hippocampus. Ann Clin Lab Sci 2017, 47:17-24.
80. Ho Y-S, Yang X, Yeung S-C, Chiu K, Lau C-F, Tsang AW-T, Mak JC-W, Chang RC-C: Cigarette Smoking Accelerated Brain Aging and Induced Pre-Alzheimer-Like Neuropathology in Rats. Plos One 2012, 7:e36752.
81. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, Tashkin DP: Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000, 161:381-390.
82. Pelkonen M, Notkola IL, Tukiainen H, Tervahauta M, Tuomilehto J, Nissinen A: Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax 2001, 56:703-707.